Vanderbilt University
717
22
56
511
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
17.2%
123 terminated/withdrawn out of 717 trials
80.6%
-5.9% vs industry average
10%
73 trials in Phase 3/4
35%
181 of 511 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (717)
Providing Access to the Visual Environment
Role: lead
PNF RCT to Decrease Alcohol Use and Increase HIV Prevention
Role: lead
Medicaid Disenrollment: Intrastate Emergency Department Impact
Role: lead
Risk Factors for Delirium Following Cardiac Surgery
Role: lead
Project PAIR: Parent-implemented Articulation Intervention With Recast
Role: lead
Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation
Role: collaborator
Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation
Role: collaborator
Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)
Role: collaborator
Randomized Controlled Trial Testing a Training Program About Section 504 of the Rehabilitation Act
Role: lead
Study of Changes in Skeletal Muscle After Caloric Restriction
Role: lead
Prevention of Anhedonia in Children
Role: lead
Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care
Role: lead
Deformable Tissue Modelling and Augmented Reality Based Guidance for Head and Neck Tumor Re-Resection Task
Role: collaborator
Adapting an Advocacy Services Intervention for Latinx Families of Transition-aged Youth With Autism Spectrum Disorder
Role: lead
Interventions for Reading Disabilities in NF1
Role: lead
Oral N-acetylcysteine for Retinitis Pigmentosa
Role: collaborator
Testing a Family Service Navigator Program for Low-resourced Families of Young Children With Autism Spectrum Disorder
Role: lead
Enhancing Parent/Caregiver Engagement in the Pediatric Intensive Care Unit (PICU): A PICU Journal
Role: collaborator
Pathways of Eicosanoid Metabolism
Role: lead
Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease
Role: lead